Position in LNTH
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$54,199,451
+$10,431,247 QoQ
Shares Held
714,561
+8.6% QoQ
Ownership
1.09%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LNTH Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MACKENZIE FINANCIAL CORP holds $92,574,463 across 16 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
175,685 | $29,609,949 | |
| 2 | ZTS |
Zoetis Inc.
|
268,075 | $19,263,869 | |
| 3 | IRWD |
Ironwood Pharmaceuticals Inc
|
2,367,493 | $9,967,145 | |
| 4 | VTRS |
Viatris Inc
|
572,287 | $9,087,917 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
15,849 | $8,587,463 | |
| 6 | CRON |
Cronos Group Inc.
|
1,597,039 | $4,439,768 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
347,299 | $3,472,990 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
91,604 | $3,103,543 |
All Filings in LNTH
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $54,199,451 | 714,561 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $43,768,204 | 657,674 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $25,726,704 | 501,593 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $40,818,915 | 498,643 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $48,549,851 | 497,437 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $19,417,829 | 217,056 | Shares | Sole | 2025-05-02 | |
| 2024-09-30 | $475,766 | 4,335 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,250,195 | 15,571 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $269,810 | 4,335 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $268,770 | 4,335 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $301,195 | 4,335 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $363,793 | 4,335 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $338,330 | 4,098 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $207,712 | 4,076 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $385,056 | 5,475 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $366,400 | 5,549 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $212,445 | 3,841 | Shares | Sole | 2022-05-13 | |
| No filing history on record for this holder in this stock. | ||||||